Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CME GROUP INC. Director's Dealing 2022

Nov 8, 2022

29871_dirs_2022-11-08_f8f112f7-49fb-4ca6-8af7-796b31201ccf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2022-01-14

Reporting Person: SHEPARD WILLIAM R (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-01-14 Common Stock Class A L 30.347 $222.28 Acquired 2114.078 Direct
2022-03-25 Common Stock Class A L 8.608 $245.59 Acquired 2122.686 Direct
2022-06-27 Common Stock Class A L 10.057 $211.06 Acquired 2132.743 Direct
2022-09-27 Common Stock Class A L 11.788 $180.93 Acquired 2144.531 Direct
2022-11-04 Common Stock Class A P 40000 $170 Acquired 239197.695 Indirect
2022-11-04 Common Stock Class A P 8645 $169.9984 Acquired 247842.695 Indirect

Footnotes

F1: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.